Cleerly’s AI can quantify coronary plaque. Can 530-patient PARAMOUNT prove it changes care?
Cleerly's 530-patient PARAMOUNT trial will reveal whether AI-QCT changes stable chest pain management. Examine the evidence and adoption stakes.
Medical Devices & Diagnostics